United States and Japan – Proton Therapy Market, Patients & Forecast
Proton therapy has become a subject of considerable interest in the radiation oncology community and it is expected that there will be a substantial growth in proton treatment facilities during the next decade. Proton therapy, one of the most intriguing developments in cancer treatment, carries a price tag as intimidating as its size. At a cost of US$ 125 Million, and sometimes much more, today’s centers usually fill a city block. Building and equipping a facility carries financial and logistical challenges that dwarf nearly any other capital project. Even health care systems with deep pockets might not have sufficient land available, particularly in urban areas.
For the year 2013 actual Proton Therapy market of United States and Japan was in Million US$, whereas; potential Proton Therapy market for United States was in double digit Billion US$ and of Japan it was in single Billion digit US$. In Unites States Actual numbers of patients for Proton Therapy is in Thousands whereas; its potential numbers of patients is in Millions. IBA & Mitsubishi dominates the proton therapy market in United States and Japan respectively. However other players like Varian, Mevion, Hitachi etc. have also started to make their presence felt in the market.
Renub Research study titled “United States and Japan – Proton Therapy Market, Patients & Forecast” provides a comprehensive assessment of the fast-evolving, high-growth of Proton Therapy Market. In this report we have studied the market in two parts a) Actual Market and b) Potential Market. The report also talks about list of all operational and future Proton Therapy centers; Economics of proton therapy including reimbursement policies. This 75 page report with 22 Figures and 9 Tables studies the Proton Therapy of 6 Companies.
Note: Actual Market is the current market which is already present
Potential Market is the market which can be achieved; but it has yet not been achieved due to demand and supply gap. At present only a few proton therapy centers are available that can treat a limited number of patients each year, but the potential candidate demand for more proton therapy centers are very high.
This report is divided into 14 Chapters
A. United States Proton Therapy Market – Actual & Potential Market (Chapter 2)
B. United States Proton Therapy Patient – Actual & Potential Candidate (Chapter 3)
C. United States – List of Proton Therapy Centers, Cost, Start of Treatment, Patient Treated (Chapter 4)
D. Proton Therapy – Comparative Analysis of Company (Chapter 5)
E. United States Proton Therapy – Company Analysis (Chapter 6)
F. Proton Therapy – Reimbursement Policies (Chapter 7)
G. Japan Proton Therapy Market –Actual & Potential Market (Chapter 8)
H. Japan Proton Therapy Patient – Actual & Potential Candidate (Chapter 9)
I. Japan –List of Proton Therapy Centers, Cost, Start of Treatment (Chapter 10)
J. Japan Proton Therapy – Company Analysis (Chapter 11)
K. Components of a Standard Proton Therapy Center (Chapter 12)
L. Proton Therapy – Driving Factors (Chapter 13)
M. Proton Therapy – Challenges (Chapter 14)
Chapter No. 5 talks of comparative analysis of Proton Therapy of companies it has been analyzed based on below mentioned points
1. Experience (Patients Treated, Clinical Rooms, Installation Time)
2. Technology (Compact 1 Room, PBS, Scattering)
Chapter No. 6 speaks of Proton Therapy centers developed by the below mentioned companies in United States
1. IBA Proton Therapy
2. Optivus Proton Therapy
3. Hitachi Proton Therapy
4. Mevion Proton Therapy
5. Varian Proton Therapy
Chapter No. 11 speaks of Proton Therapy centers developed by the below mentioned companies in Japan
1. Mitsubishi Proton Therapy
2. IBA Proton Therapy
Data Sources
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.
Primary sources include industry surveys and telephone interviews with industry experts.
Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.
For the year 2013 actual Proton Therapy market of United States and Japan was in Million US$, whereas; potential Proton Therapy market for United States was in double digit Billion US$ and of Japan it was in single Billion digit US$. In Unites States Actual numbers of patients for Proton Therapy is in Thousands whereas; its potential numbers of patients is in Millions. IBA & Mitsubishi dominates the proton therapy market in United States and Japan respectively. However other players like Varian, Mevion, Hitachi etc. have also started to make their presence felt in the market.
Renub Research study titled “United States and Japan – Proton Therapy Market, Patients & Forecast” provides a comprehensive assessment of the fast-evolving, high-growth of Proton Therapy Market. In this report we have studied the market in two parts a) Actual Market and b) Potential Market. The report also talks about list of all operational and future Proton Therapy centers; Economics of proton therapy including reimbursement policies. This 75 page report with 22 Figures and 9 Tables studies the Proton Therapy of 6 Companies.
Note: Actual Market is the current market which is already present
Potential Market is the market which can be achieved; but it has yet not been achieved due to demand and supply gap. At present only a few proton therapy centers are available that can treat a limited number of patients each year, but the potential candidate demand for more proton therapy centers are very high.
This report is divided into 14 Chapters
A. United States Proton Therapy Market – Actual & Potential Market (Chapter 2)
B. United States Proton Therapy Patient – Actual & Potential Candidate (Chapter 3)
C. United States – List of Proton Therapy Centers, Cost, Start of Treatment, Patient Treated (Chapter 4)
D. Proton Therapy – Comparative Analysis of Company (Chapter 5)
E. United States Proton Therapy – Company Analysis (Chapter 6)
F. Proton Therapy – Reimbursement Policies (Chapter 7)
G. Japan Proton Therapy Market –Actual & Potential Market (Chapter 8)
H. Japan Proton Therapy Patient – Actual & Potential Candidate (Chapter 9)
I. Japan –List of Proton Therapy Centers, Cost, Start of Treatment (Chapter 10)
J. Japan Proton Therapy – Company Analysis (Chapter 11)
K. Components of a Standard Proton Therapy Center (Chapter 12)
L. Proton Therapy – Driving Factors (Chapter 13)
M. Proton Therapy – Challenges (Chapter 14)
Chapter No. 5 talks of comparative analysis of Proton Therapy of companies it has been analyzed based on below mentioned points
1. Experience (Patients Treated, Clinical Rooms, Installation Time)
2. Technology (Compact 1 Room, PBS, Scattering)
Chapter No. 6 speaks of Proton Therapy centers developed by the below mentioned companies in United States
1. IBA Proton Therapy
2. Optivus Proton Therapy
3. Hitachi Proton Therapy
4. Mevion Proton Therapy
5. Varian Proton Therapy
Chapter No. 11 speaks of Proton Therapy centers developed by the below mentioned companies in Japan
1. Mitsubishi Proton Therapy
2. IBA Proton Therapy
Data Sources
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.
Primary sources include industry surveys and telephone interviews with industry experts.
Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.
1. EXECUTIVE SUMMARY
2. UNITED STATES PROTON THERAPY MARKET – ACTUAL & POTENTIAL MARKET
2.1 United States – Proton Therapy Market
2.2 United States – Potential Proton Therapy Market
3. UNITED STATES PROTON THERAPY PATIENT NUMBER – ACTUAL AND POTENTIAL
3.1 United States – Patients Treated with Proton Therapy Actual Numbers & Forecast
3.2 United States – Patients with Proton Therapy Potential Numbers & Forecast
4. UNITED STATES – LIST OF PROTON THERAPY CENTERS, COST, START OF TREATMENT, PATIENT TREATED
5. PROTON THERAPY – COMPARATIVE ANALYSIS OF COMPANY
6. UNITED STATES PROTON THERAPY – COMPANY ANALYSIS
6.1 IBA Proton Therapy
6.1.1 IBA Proton Therapy Sales (2007 – 2015)
6.1.2 The Proton Therapy Centers Developed by IBA
6.2 Optivus Proton Therapy
6.2.1 The Proton Therapy Centers Developed by Optivus
6.3 Hitachi Proton Therapy
6.3.1 The Proton Therapy Centers Developed by Hitachi
6.4 Mevion Proton Therapy
6.4.1 The Proton Therapy Centers Developed by Mevion
6.5 Varian Proton Therapy
6.5.1 The Proton Therapy Centers Developed by Varian
7. PROTON THERAPY – REIMBURSEMENT POLICIES
8. JAPAN PROTON THERAPY MARKET – ACTUAL & POTENTIAL MARKET
8.1 Japan – Proton Therapy Actual Market & Forecast
8.2 Japan – Potential Proton Therapy Market
9. JAPAN PROTON THERAPY PATIENT – ACTUAL & POTENTIAL CANDIDATE
9.1 Japan – Patient Treated with Proton Therapy Actual Numbers & Forecast
9.2 Japan – Potential Candidate for Proton Therapy
10. JAPAN – LIST OF PROTON THERAPY CENTERS, COST, START OF TREATMENT
11. JAPAN PROTON THERAPY – COMPANY ANALYSIS
11.1 The Proton Therapy Centers Developed by Mitsubishi
11.2 The Proton Therapy Centers Developed by IBA
12. COMPONENTS OF A STANDARD PROTON THERAPY CENTER
12.1 Proton Accelerator
12.2 Beam Transport System
12.3 Beam Delivery System
12.3.1 The Passive Scattering Technique
12.3.2 Beam Scanning
12.4 Nozzle
12.4.1 Single Scattering
12.4.2 Double Scattering
12.4.3 Uniform Scanning Nozzle
12.4.4 Pencil Scanning Nozzle
12.5 Treatment Planning System
12.6 Image Viewers
12.7 Patient Positioning System (PPS)
12.8 Human Resource
13. PROTON THERAPY – DRIVING FACTORS
13.1 Technology Advancement
13.2 Growing Incidence of Cancer Patients
13.3 Advantages of Proton Therapy
14. PROTON THERAPY – CHALLENGES
14.1 Requires Huge Investment
14.2 Operations Challenges
2. UNITED STATES PROTON THERAPY MARKET – ACTUAL & POTENTIAL MARKET
2.1 United States – Proton Therapy Market
2.2 United States – Potential Proton Therapy Market
3. UNITED STATES PROTON THERAPY PATIENT NUMBER – ACTUAL AND POTENTIAL
3.1 United States – Patients Treated with Proton Therapy Actual Numbers & Forecast
3.2 United States – Patients with Proton Therapy Potential Numbers & Forecast
4. UNITED STATES – LIST OF PROTON THERAPY CENTERS, COST, START OF TREATMENT, PATIENT TREATED
5. PROTON THERAPY – COMPARATIVE ANALYSIS OF COMPANY
6. UNITED STATES PROTON THERAPY – COMPANY ANALYSIS
6.1 IBA Proton Therapy
6.1.1 IBA Proton Therapy Sales (2007 – 2015)
6.1.2 The Proton Therapy Centers Developed by IBA
6.2 Optivus Proton Therapy
6.2.1 The Proton Therapy Centers Developed by Optivus
6.3 Hitachi Proton Therapy
6.3.1 The Proton Therapy Centers Developed by Hitachi
6.4 Mevion Proton Therapy
6.4.1 The Proton Therapy Centers Developed by Mevion
6.5 Varian Proton Therapy
6.5.1 The Proton Therapy Centers Developed by Varian
7. PROTON THERAPY – REIMBURSEMENT POLICIES
8. JAPAN PROTON THERAPY MARKET – ACTUAL & POTENTIAL MARKET
8.1 Japan – Proton Therapy Actual Market & Forecast
8.2 Japan – Potential Proton Therapy Market
9. JAPAN PROTON THERAPY PATIENT – ACTUAL & POTENTIAL CANDIDATE
9.1 Japan – Patient Treated with Proton Therapy Actual Numbers & Forecast
9.2 Japan – Potential Candidate for Proton Therapy
10. JAPAN – LIST OF PROTON THERAPY CENTERS, COST, START OF TREATMENT
11. JAPAN PROTON THERAPY – COMPANY ANALYSIS
11.1 The Proton Therapy Centers Developed by Mitsubishi
11.2 The Proton Therapy Centers Developed by IBA
12. COMPONENTS OF A STANDARD PROTON THERAPY CENTER
12.1 Proton Accelerator
12.2 Beam Transport System
12.3 Beam Delivery System
12.3.1 The Passive Scattering Technique
12.3.2 Beam Scanning
12.4 Nozzle
12.4.1 Single Scattering
12.4.2 Double Scattering
12.4.3 Uniform Scanning Nozzle
12.4.4 Pencil Scanning Nozzle
12.5 Treatment Planning System
12.6 Image Viewers
12.7 Patient Positioning System (PPS)
12.8 Human Resource
13. PROTON THERAPY – DRIVING FACTORS
13.1 Technology Advancement
13.2 Growing Incidence of Cancer Patients
13.3 Advantages of Proton Therapy
14. PROTON THERAPY – CHALLENGES
14.1 Requires Huge Investment
14.2 Operations Challenges
LIST OF FIGURES:
Figure 2 1: United States – Proton Therapy Market (Million US$), 2009 – 2013
Figure 2 2: United States – Forecast for Proton Therapy Market (Million US$), 2014 – 2018
Figure 2 3: United States – Potential Proton Therapy Market (Million US$), 2009 – 2013
Figure 2 4: United States – Forecast for Potential Proton Therapy Market (Million US$), 2014 – 2018
Figure 3 1: United States – Patient Treated with Proton Therapy (Number), 2009 – 2013
Figure 3 2: United States – Forecast for Patient Treated with Proton Therapy (Number), 2014 – 2018
Figure 3 3: United States – Potential Candidate for Proton Therapy (Number), 2009 – 2013
Figure 3 4: United States – Forecast for Potential Candidate for Proton Therapy (Number), 2014 – 2018
Figure 6 1: United States – IBA Proton Therapy Sales (Million US$), 2007 – 2013
Figure 6 2: United States – Forecast for IBA Proton Therapy Sales (Million US$), 2014 – 2015
Figure 8 1: Japan – Proton Therapy Market (Million US$), 2003 – 2013
Figure 8 2: Japan – Forecast for Proton Therapy Market (Million US$), 2014 – 2018
Figure 8 3: Japan – Potential Proton Therapy Market (Million US$), 2005 – 2013
Figure 8 4: Japan – Forecast for Potential Proton Therapy Market (Million US$), 2014 – 2018
Figure 9 1: Japan – Patient Treated with Proton Therapy (Number), 2003 – 2013
Figure 9 2: Japan – Forecast for Patient Treated with Proton Therapy (Number), 2014 – 2018
Figure 9 3: Japan – Potential Candidate for Proton Therapy (Number), 2005 – 2013
Figure 9 4: Japan – Forecast for Potential Candidate for Proton Therapy (Number), 2014 – 2018
Figure 13 1: United States – Number of Patient Diagnosed With Cancer (Million), 2009 – 2013
Figure 13 2: United States – Forecast for Number of Patient Diagnosed With Cancer (Million), 2014 – 2018
Figure 13 3: Japan – Number of Patient Diagnosed With Cancer (Million), 2005 – 2013
Figure 13 4: Japan – Forecast for Number of Patient Diagnosed With Cancer (Million), 2014 – 2018
Figure 2 1: United States – Proton Therapy Market (Million US$), 2009 – 2013
Figure 2 2: United States – Forecast for Proton Therapy Market (Million US$), 2014 – 2018
Figure 2 3: United States – Potential Proton Therapy Market (Million US$), 2009 – 2013
Figure 2 4: United States – Forecast for Potential Proton Therapy Market (Million US$), 2014 – 2018
Figure 3 1: United States – Patient Treated with Proton Therapy (Number), 2009 – 2013
Figure 3 2: United States – Forecast for Patient Treated with Proton Therapy (Number), 2014 – 2018
Figure 3 3: United States – Potential Candidate for Proton Therapy (Number), 2009 – 2013
Figure 3 4: United States – Forecast for Potential Candidate for Proton Therapy (Number), 2014 – 2018
Figure 6 1: United States – IBA Proton Therapy Sales (Million US$), 2007 – 2013
Figure 6 2: United States – Forecast for IBA Proton Therapy Sales (Million US$), 2014 – 2015
Figure 8 1: Japan – Proton Therapy Market (Million US$), 2003 – 2013
Figure 8 2: Japan – Forecast for Proton Therapy Market (Million US$), 2014 – 2018
Figure 8 3: Japan – Potential Proton Therapy Market (Million US$), 2005 – 2013
Figure 8 4: Japan – Forecast for Potential Proton Therapy Market (Million US$), 2014 – 2018
Figure 9 1: Japan – Patient Treated with Proton Therapy (Number), 2003 – 2013
Figure 9 2: Japan – Forecast for Patient Treated with Proton Therapy (Number), 2014 – 2018
Figure 9 3: Japan – Potential Candidate for Proton Therapy (Number), 2005 – 2013
Figure 9 4: Japan – Forecast for Potential Candidate for Proton Therapy (Number), 2014 – 2018
Figure 13 1: United States – Number of Patient Diagnosed With Cancer (Million), 2009 – 2013
Figure 13 2: United States – Forecast for Number of Patient Diagnosed With Cancer (Million), 2014 – 2018
Figure 13 3: Japan – Number of Patient Diagnosed With Cancer (Million), 2005 – 2013
Figure 13 4: Japan – Forecast for Number of Patient Diagnosed With Cancer (Million), 2014 – 2018
LIST OF TABLES:
Table 4 1: United States – Proton Therapy Facilities in Operation and in Development Phase
Table 5 1: Proton Therapy – Comparative Analysis of Company, 2012
Table 6 1: United States – IBA Proton Therapy Centers, 2001 – 2015
Table 6 2: United States – Hitachi Proton Therapy Centers, 2006 – 2016
Table 6 3: United States – Mevion Proton Therapy Centers
Table 6 4: United States – Varian Proton Therapy Centers, 2014
Table 10 1: Japan – Proton Therapy Centers, (1994 – 2016)
Table 11 1: Japan – Mitsubishi Proton Therapy Centers, (1994 – 2016)
Table 11 2: Japan – IBA Proton Therapy Centers, 1998
Table 4 1: United States – Proton Therapy Facilities in Operation and in Development Phase
Table 5 1: Proton Therapy – Comparative Analysis of Company, 2012
Table 6 1: United States – IBA Proton Therapy Centers, 2001 – 2015
Table 6 2: United States – Hitachi Proton Therapy Centers, 2006 – 2016
Table 6 3: United States – Mevion Proton Therapy Centers
Table 6 4: United States – Varian Proton Therapy Centers, 2014
Table 10 1: Japan – Proton Therapy Centers, (1994 – 2016)
Table 11 1: Japan – Mitsubishi Proton Therapy Centers, (1994 – 2016)
Table 11 2: Japan – IBA Proton Therapy Centers, 1998
